Potent Anticarcinoma Activity of the Humanized Anti-CD70 Antibody h1F6 Conjugated to the Tubulin Inhibitor Auristatin via an Uncleavable LinkerOFLAZOGLU, Ezogelin; STONE, Ivan J; GORDON, Kristine et al.Clinical cancer research (Print). 2008, Vol 14, Num 19, pp 6171-6180, issn 1078-0432, 10 p.Article

Development of novel humanized anti-CD20 antibodies based on affinity constant and epitopeUCHIYAMA, Susumu; SUZUKI, Yasuhiko; FUKUI, Kiichi et al.Cancer science. 2010, Vol 101, Num 1, pp 201-209, issn 1347-9032, 9 p.Article

HMMC-1: A humanized monoclonal antibody with therapeutic potential against Müllerian duct-related carcinomasNOZAWA, Shiro; AOKI, Daisuke; KOJIMA-AIKAWA, Kyoko et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 7071-7078, issn 1078-0432, 8 p.Article

Targeted gene delivery using humanized single-chain antibody with negatively charged oligopeptide tailSUZUKI, Masataka; TAKAYANAGI, Atsushi; SHIMIZU, Nobuyoshi et al.Cancer science. 2004, Vol 95, Num 5, pp 424-429, issn 1347-9032, 6 p.Article

A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy AdultsROBBIE, Gabriel J; CRISTE, Ryan; DALL'ACQUA, William F et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 6147-6153, issn 0066-4804, 7 p.Article

Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibodyGOLDENBERG, David M; ROSSI, Edmund A; STEIN, Rhona et al.Blood. 2009, Vol 113, Num 5, pp 1062-1070, issn 0006-4971, 9 p.Article

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesisCORREN, Jonathan; DIAZ-SANCHEZ, David; SAXON, Andrew et al.Annals of allergy, asthma, & immunology. 2004, Vol 93, Num 3, pp 243-248, issn 1081-1206, 6 p.Article

Purification of humanized monoclonal antibodies by membrane-based hybrid bioseparation techniqueLU WANG; KANANI, Dharmesh M; GHOSH, Raja et al.Journal of immunological methods. 2006, Vol 314, Num 1-2, pp 1-8, issn 0022-1759, 8 p.Article

Characterization of humanized antibody produced by apoptosis-resistant CHO cells under sodium butyrate-induced conditionKIM, No Soo; KERN HEE CHANG; BO SUP CHUNG et al.Journal of microbiology and biotechnology. 2003, Vol 13, Num 6, pp 926-936, issn 1017-7825, 11 p.Article

Les anticorps appelés à la rescousse = Antibodies to the rescueENGLAND, Patrick; LAFAYE, Pierre.Biofutur (Puteaux). 2001, Vol 217, pp 78-81, issn 0294-3506Article

Mcl-1 Overexpression Leads to Higher Viabilities and Increased Production of Humanized Monoclonal Antibody in Chinese Hamster Ovary CellsMAJORS, Brian S; BETENBAUGH, Michael J; PEDERSON, Nels E et al.Biotechnology progress. 2009, Vol 25, Num 4, pp 1161-1168, issn 8756-7938, 8 p.Article

Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activitiesSHIAO, Stephen L; MCNIFF, Jennifer M; MASUNAGA, Taro et al.Transplantation. 2007, Vol 83, Num 3, pp 304-313, issn 0041-1337, 10 p.Article

Le point sur les anticorps autorisés en imagerie et en immunothérapie = Approved antibodies for imaging and therapeutic : an updateBATY, D; CHAMES, P.Immuno analyse & biologie spécialisée. 2006, Vol 21, Num 5, pp 255-263, issn 0923-2532, 9 p.Article

Anticorps monoclonaux et recombinants, 30 ans déjà.. = Monoclonal antibodies, 30 years of success..LAFFLY, Emmanuelle; SODOYER, Régis.Journal de la Société de biologie. 2006, Vol 200, Num 4, pp 325-343, issn 1295-0661, 19 p.Conference Paper

Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureusDOMANSKI, Paul J; PATEL, Pratiksha R; PATTI, Joseph M et al.Infection and immunity. 2005, Vol 73, Num 8, pp 5229-5232, issn 0019-9567, 4 p.Article

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38⁺ Hematologic MalignanciesDECKERT, Jutta; WETZEL, Marie-Cécile; DUMONTET, Charles et al.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4574-4583, issn 1078-0432, 10 p.Article

Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemiasGUPTA, Pankaj; GOLDENBERG, David M; ROSSI, Edmund A et al.Blood. 2010, Vol 116, Num 17, pp 3258-3267, issn 0006-4971, 10 p.Article

Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile VirusSHULIU ZHANG; VOGT, Matthew R; OLIPHANT, Theodore et al.The Journal of infectious diseases. 2009, Vol 200, Num 2, pp 202-205, issn 0022-1899, 4 p.Article

A Humanized Tumor Necrosis Factor Receptor 1 (TNFR1)-specific Antagonistic Antibody for Selective Inhibition of Tumor Necrosis Factor (TNF) ActionKONTERMANN, Roland E; MÜNKEL, Sabine; NEUMEYER, Jens et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 3, pp 225-234, issn 1524-9557, 10 p.Article

Limitations to the development of humanized antibody producing chinese hamster ovary cells using glutamine synthetase-mediated gene amplificationSEUNG CHUL JUN; MIN SOO KIM; HYO JEONG HONG et al.Biotechnology progress. 2006, Vol 22, Num 3, pp 770-780, issn 8756-7938, 11 p.Article

Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth : An extracellular matrix-based therapeutic approachPERNASETTI, Flavia; NICKEL, Jeffrey; CLARK, Derek et al.International journal of oncology. 2006, Vol 29, Num 6, pp 1371-1379, issn 1019-6439, 9 p.Article

Mechanisms by which SGN-40, a humanized anti-cd40 antibody, induces cytotoxicity in human multiple myeloma cells: Clinical implicationsTAI, Yu-Tzu; CATLEY, Laurence P; RICHARDSON, Paul et al.Cancer research (Baltimore). 2004, Vol 64, Num 8, pp 2846-2852, issn 0008-5472, 7 p.Article

Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector functionTAI, Yu-Tzu; HORTON, Holly M; LAZAR, Greg A et al.Blood. 2012, Vol 119, Num 9, pp 2074-2082, issn 0006-4971, 9 p.Article

The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemiaLAPALOMBELLA, Rosa; GOWDA, Aruna; MUTHUSAMY, Natarajan et al.British journal of haematology. 2009, Vol 144, Num 6, pp 848-855, issn 0007-1048, 8 p.Article

A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the lewis-Y antigenSCOTT, Andrew M; TEBBUTT, Niall; MACGREGOR, Duncan et al.Clinical cancer research. 2007, Vol 13, Num 11, pp 3286-3292, issn 1078-0432, 7 p.Article